Akpak Yaşam Kemal, Aktürk Erhan, Oral Serkan, Kıncı Mehmet Ferdi, Kanmaz Ahkam Göksel, Bozgeyik Mehmet Bora, Töz Emrah
Department of Obstetrics and Gynaecology, Izmir City Hospital, Izmir, Turkey.
Izmir Faculty of Medicine, Department of Obstetrics and Gynaecology, University of Health Sciences, Izmir, Turkey.
Arch Gynecol Obstet. 2025 Apr;311(4):933-940. doi: 10.1007/s00404-024-07923-2. Epub 2025 Jan 25.
Female Genital Mutilation/Cutting (FGM/C) is a surgical intervention that is still performed in large numbers worldwide and has severe effects in terms of both obstetric and sexual consequences. Due to the increase in immigration, it has become more frequent in many countries. This study aims to compare the labor performance, complications, and postpartum sexual function of Type 3 Female Genital Mutilation/Cutting (FGM/C) pregnant women undergoing deinfibulation with Type 3 FGM/C patients without deinfibulation.
This is a prospective study of pregnant women with Type 3 FGM/C and puerperium patients at Nyala Turkish Training and Research Hospital in Sudan over 4 years, from September 2018 to September 2022. Type 3 FGM/C patients who underwent deinfibulation were compared with those who did not, considering age, parity, and obstetric and neonatal outcomes and the Female Sexual Function Index (FSFI) scores at 3 months.
In our homogeneous Type 3 FGM/C group mainly consisting of primiparous women, it was found that more episiotomy procedures were performed. The second stage of labor was significantly prolonged, and perineal damage was greater in the group without deinfibulation. In addition, postpartum hemorrhage and hospitalization of mother and baby were longer in the group without deinfibulation. In the second part of our study, we compared the FSFI scores between the deinfibulation group and the episiotomy subgroup. The results indicated that the deinfibulation group exhibited higher scores across all FSFI domains.
Type 3 FGM/C is definitely associated with poor obstetric and sexual outcomes. It is essential to include partners in family discussions and to protect the perineum by performing deinfibulation and episiotomy at appropriate times and in the correct manner during labor.
The contribution of the deinfibulation procedure, which is recognized for its obstetric benefits, should also be communicated to families and spouses in terms of its long-term impact on sexual performance. By sharing this information, the devastating effects of Female Genital Mutilation/Cutting (FGM/C) can be mitigated, both obstetrically and sexually.
女性生殖器切割(FGM/C)是一种外科手术干预措施,在全球范围内仍大量存在,在产科和性方面均有严重影响。由于移民增加,在许多国家这种手术变得更加频繁。本研究旨在比较接受去纤维化手术的3型女性生殖器切割(FGM/C)孕妇与未接受去纤维化手术的3型FGM/C患者的分娩情况、并发症及产后性功能。
这是一项对苏丹尼亚拉土耳其培训与研究医院2018年9月至2022年9月期间的3型FGM/C孕妇及产褥期患者进行的为期4年的前瞻性研究。将接受去纤维化手术的3型FGM/C患者与未接受该手术的患者进行比较,考虑年龄、产次、产科和新生儿结局以及3个月时的女性性功能指数(FSFI)评分。
在我们主要由初产妇组成的同质3型FGM/C组中,发现进行会阴切开术的情况更多。未接受去纤维化手术的组第二产程明显延长,会阴损伤更大。此外,未接受去纤维化手术的组产后出血以及母婴住院时间更长。在我们研究的第二部分,我们比较了去纤维化组和会阴切开术亚组的FSFI评分。结果表明,去纤维化组在所有FSFI领域的得分更高。
3型FGM/C肯定与不良的产科和性结局相关。在家庭讨论中纳入伴侣,并在分娩期间适时以正确方式进行去纤维化手术和会阴切开术以保护会阴至关重要。
去纤维化手术因其产科益处而得到认可,其对性功能的长期影响也应告知家庭和配偶。通过分享这些信息,女性生殖器切割(FGM/C)在产科和性方面的破坏性影响均可得到减轻。